These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35115795)

  • 1. Nephrotoxicity and Efficacy Assessment of Polymyxin B Use in Renal Transplant Patients.
    Wen YX; Qu Q; Long WM; Luo Y; Zhuang HH; Teng XQ; Qu J
    Infect Drug Resist; 2022; 15():275-283. PubMed ID: 35115795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin B-Associated Nephrotoxicity and Its Predictors: A Retrospective Study in Carbapenem-Resistant Gram-Negative Bacterial Infections.
    Wu XL; Long WM; Lu Q; Teng XQ; Qi TT; Qu Q; He GF; Qu J
    Front Pharmacol; 2022; 13():672543. PubMed ID: 35571125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B-Based Regimens for Patients Infected with Carbapenem-Resistant Gram-Negative Bacteria: Clinical and Microbiological Efficacy, Mortality, and Safety.
    Qu J; Qi TT; Qu Q; Long WM; Chen Y; Luo Y; Wang Y
    Infect Drug Resist; 2022; 15():1205-1218. PubMed ID: 35345474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B.
    John JF; Falci DR; Rigatto MH; Oliveira RD; Kremer TG; Zavascki AP
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin versus polymyxin B: A pragmatic assessment of renal and neurological adverse effects and effectiveness in multidrug-resistant Gram-negative bacterial infections.
    Simon V; Viswam A; Alexander PS; James E; Sudhindran S
    Indian J Pharmacol; 2023; 55(4):229-236. PubMed ID: 37737075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity Associated with Intravenous Polymyxin B Once- versus Twice-Daily Dosing Regimen.
    Okoduwa A; Ahmed N; Guo Y; Scipione MR; Papadopoulos J; Eiras DP; Dubrovskaya Y
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of polymyxin-B-associated acute kidney injury in 1-year mortality and renal function recovery.
    Gomes EC; Falci DR; Bergo P; Zavascki AP; Rigatto MH
    Int J Antimicrob Agents; 2018 Jul; 52(1):86-89. PubMed ID: 29501603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
    Rigatto MH; Oliveira MS; Perdigão-Neto LV; Levin AS; Carrilho CM; Tanita MT; Tuon FF; Cardoso DE; Lopes NT; Falci DR; Zavascki AP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2443-9. PubMed ID: 26856846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients.
    Deng Y; Gu JY; Li X; Tong H; Guo SW; Xu B; Li Y; Zhang BK; Li Y; Huang HY; Xiao GY
    Infect Dis Ther; 2022 Aug; 11(4):1591-1608. PubMed ID: 35689791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective observational study of the treatment with polymyxin B for liver transplantation recipients infected by multidrug-resistant gram-negative bacteria.
    Yu LL; Shi XP; Huang JF; Gong Y; Cui CX; Wang T
    J Clin Pharm Ther; 2022 Oct; 47(10):1563-1569. PubMed ID: 35670240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms.
    Lu Q; Li GH; Qu Q; Zhu HH; Luo Y; Yan H; Yuan HY; Qu J
    Infect Drug Resist; 2021; 14():1979-1988. PubMed ID: 34093026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome C suppresses renal accumulation and nephrotoxicity of polymyxin B.
    Li ZD; Luo J; Jia LH; Wang XY; Xun ZK; Liu M
    Hum Exp Toxicol; 2019 Feb; 38(2):193-200. PubMed ID: 30016892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of heme oxygenase-1 in polymyxin B-induced nephrotoxicity in rats.
    Dezoti Fonseca C; Watanabe M; Vattimo Mde F
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5082-7. PubMed ID: 22802257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury.
    Sisay M; Hagos B; Edessa D; Tadiwos Y; Mekuria AN
    Pharmacol Res; 2021 Jan; 163():105328. PubMed ID: 33276108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China.
    Wu X; Huang C; Wang H; Ji J; Ying C; Xiao Y
    Drug Des Devel Ther; 2021; 15():2593-2603. PubMed ID: 34168431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of polymyxin B in patients with liver dysfunction.
    Li X; Cheng Y; Chen B; Chen Y; Huang Y; Zhang B; Que W; Liu M; Zhang H; Qiu H
    Br J Clin Pharmacol; 2023 Dec; 89(12):3561-3572. PubMed ID: 37461291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study.
    Aggarwal R; Dewan A
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):15. PubMed ID: 29571295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Study of the Microbiological Efficacy of Polymyxin B on Different Carbapenem-Resistant Gram-Negative Bacteria Infections.
    Lu Q; Zhu HH; Li GH; Qi TT; Ye LJ; Teng XQ; Qu Q; He GF; Qu J
    Front Med (Lausanne); 2021; 8():620885. PubMed ID: 33634151
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating nephrotoxicity reduction in a novel polymyxin B formulation: insights from a 3D kidney-on-a-chip model.
    Payasi A; Yadav MK; Chaudhary S; Aggarwal A
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0021924. PubMed ID: 39225483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis.
    Vardakas KZ; Falagas ME
    Int J Antimicrob Agents; 2017 Feb; 49(2):233-238. PubMed ID: 27686609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.